Engineering neuroblastoma models for clinical translation
Neuroblastoma is a profoundly heterogenous extracranial solid tumor in pediatric patients. Elevated risk grade of neuroblastoma has been correlated with unsatisfactory prognosis and resistance to chemotherapy. Despite multimodal therapies exploited for killing neuroblastoma tumor cells, in high-risk...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-01-01
|
| Series: | Engineered Regeneration |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666138125000088 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849320108451692544 |
|---|---|
| author | Taiyu Song Rui Liu Feika Bian Bin Kong Jingjing Gan |
| author_facet | Taiyu Song Rui Liu Feika Bian Bin Kong Jingjing Gan |
| author_sort | Taiyu Song |
| collection | DOAJ |
| description | Neuroblastoma is a profoundly heterogenous extracranial solid tumor in pediatric patients. Elevated risk grade of neuroblastoma has been correlated with unsatisfactory prognosis and resistance to chemotherapy. Despite multimodal therapies exploited for killing neuroblastoma tumor cells, in high-risk neuroblastoma patients, the long-term survival is currently less than 50%. Promising approaches to evaluating the extent of heterogeneity via gene expression profiling of cell subpopulations within individual tumors are still lacking. There is uncertainty about the cross-talk between neuroblastoma cells and other non-neoplastic cell components in the tumor microenvironment. Recently, concerns about individualized eradication therapies have advanced the demand for the diversified construction of neuroblastoma tumor models. This review briefly introduces the genetic variation, subpopulations, and tumor microenvironment aspects of neuroblastoma heterogeneity. Then, we summarize recent methods of constructing tumor models to mimic the biological features of neuroblastoma tumors in vitro. Finally, we conclude the future trends and perspectives in neuroblastoma tumor therapy. |
| format | Article |
| id | doaj-art-2f769b2db45f4ab6a57b8f9beaf3b1e4 |
| institution | Kabale University |
| issn | 2666-1381 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | KeAi Communications Co., Ltd. |
| record_format | Article |
| series | Engineered Regeneration |
| spelling | doaj-art-2f769b2db45f4ab6a57b8f9beaf3b1e42025-08-20T03:50:12ZengKeAi Communications Co., Ltd.Engineered Regeneration2666-13812025-01-01614615910.1016/j.engreg.2025.05.002Engineering neuroblastoma models for clinical translationTaiyu Song0Rui Liu1Feika Bian2Bin Kong3Jingjing Gan4Department of Pediatrics, Institute of Translational Medicine, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210002, ChinaInstitute of Translational Medicine, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210002, ChinaZhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325035, China; Corresponding authors.Department of Biomedical Engineering, School of Medicine, Shenzhen University, Shenzhen, Guangdong 518000, China; Corresponding authors.Institute of Translational Medicine, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210002, China; Corresponding authors.Neuroblastoma is a profoundly heterogenous extracranial solid tumor in pediatric patients. Elevated risk grade of neuroblastoma has been correlated with unsatisfactory prognosis and resistance to chemotherapy. Despite multimodal therapies exploited for killing neuroblastoma tumor cells, in high-risk neuroblastoma patients, the long-term survival is currently less than 50%. Promising approaches to evaluating the extent of heterogeneity via gene expression profiling of cell subpopulations within individual tumors are still lacking. There is uncertainty about the cross-talk between neuroblastoma cells and other non-neoplastic cell components in the tumor microenvironment. Recently, concerns about individualized eradication therapies have advanced the demand for the diversified construction of neuroblastoma tumor models. This review briefly introduces the genetic variation, subpopulations, and tumor microenvironment aspects of neuroblastoma heterogeneity. Then, we summarize recent methods of constructing tumor models to mimic the biological features of neuroblastoma tumors in vitro. Finally, we conclude the future trends and perspectives in neuroblastoma tumor therapy.http://www.sciencedirect.com/science/article/pii/S2666138125000088NeuroblastomaHeterogeneityTumor microenvironmentTumor models |
| spellingShingle | Taiyu Song Rui Liu Feika Bian Bin Kong Jingjing Gan Engineering neuroblastoma models for clinical translation Engineered Regeneration Neuroblastoma Heterogeneity Tumor microenvironment Tumor models |
| title | Engineering neuroblastoma models for clinical translation |
| title_full | Engineering neuroblastoma models for clinical translation |
| title_fullStr | Engineering neuroblastoma models for clinical translation |
| title_full_unstemmed | Engineering neuroblastoma models for clinical translation |
| title_short | Engineering neuroblastoma models for clinical translation |
| title_sort | engineering neuroblastoma models for clinical translation |
| topic | Neuroblastoma Heterogeneity Tumor microenvironment Tumor models |
| url | http://www.sciencedirect.com/science/article/pii/S2666138125000088 |
| work_keys_str_mv | AT taiyusong engineeringneuroblastomamodelsforclinicaltranslation AT ruiliu engineeringneuroblastomamodelsforclinicaltranslation AT feikabian engineeringneuroblastomamodelsforclinicaltranslation AT binkong engineeringneuroblastomamodelsforclinicaltranslation AT jingjinggan engineeringneuroblastomamodelsforclinicaltranslation |